READ THE FULL PUBLICATION here (Adobe Acrobat Reader required to view this article).  

POR JUAN LUIS SERRANO Prompt and affordable access to essential medicines is a component of almost all domestic and global public health models. As is now well known, the availability and costs of both brand and generic drugs is a function of traditional patent law incentives. Less known, however, is that generic entry is controlled increasingly[...]

READ FULL ARTICLE HERE (Adobe Acrobat Reader required)